enfortumab vedotin
astellas,seagen
['bladder']
#asco22 outstanding discussion by on strategy in neoadjuvant rx and drug development in #bladdercancer : i have failed over and over again in my life, and that s why i succeed. 
Medical Oncologist. Editor-in-chief: @ASCO Daily News; Presidential Endowed Chair, @HuntsmanCancer (NCI-CCC) @UUtah, FCOI https://t.co/qcdl195o3E